These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9496698

  • 1. Distribution and concentration of urocortin, and effect of adrenalectomy on its content in rat hypothalamus.
    Oki Y, Iwabuchi M, Masuzawa M, Watanabe F, Ozawa M, Iino K, Tominaga T, Yoshimi T.
    Life Sci; 1998; 62(9):807-12. PubMed ID: 9496698
    [Abstract] [Full Text] [Related]

  • 2. Immunoreactive delta sleep-inducing peptide in the rat hypothalamus, pituitary and adrenal gland: effects of adrenalectomy.
    Bjartell A, Sundler F, Ekman R.
    Horm Res; 1991; 36(1-2):52-62. PubMed ID: 1814802
    [Abstract] [Full Text] [Related]

  • 3. Corticotropin-releasing factor but not urocortin is involved in adrenalectomy-induced adrenocorticotropin release.
    Masuzawa M, Oki Y, Ozawa M, Watanabe F, Yoshimi T.
    J Neuroendocrinol; 1999 Jan; 11(1):71-4. PubMed ID: 9918231
    [Abstract] [Full Text] [Related]

  • 4. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
    Bagosi Z, Csabafi K, Palotai M, Jászberényi M, Földesi I, Gardi J, Szabó G, Telegdy G.
    Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
    [Abstract] [Full Text] [Related]

  • 5. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
    Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, Sawchenko PE.
    J Comp Neurol; 1999 Dec 20; 415(3):285-312. PubMed ID: 10553117
    [Abstract] [Full Text] [Related]

  • 6. Distribution of urocortin 2 in various tissues of the rat.
    Yamauchi N, Otagiri A, Nemoto T, Sekino A, Oono H, Kato I, Yanaihara C, Shibasaki T.
    J Neuroendocrinol; 2005 Oct 20; 17(10):656-63. PubMed ID: 16159378
    [Abstract] [Full Text] [Related]

  • 7. Expression of urocortin III/stresscopin in human heart and kidney.
    Takahashi K, Totsune K, Murakami O, Saruta M, Nakabayashi M, Suzuki T, Sasano H, Shibahara S.
    J Clin Endocrinol Metab; 2004 Apr 20; 89(4):1897-903. PubMed ID: 15070962
    [Abstract] [Full Text] [Related]

  • 8. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
    Henry BA, Lightman SL, Lowry CA.
    J Neuroendocrinol; 2005 Mar 20; 17(3):135-44. PubMed ID: 15796765
    [Abstract] [Full Text] [Related]

  • 9. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.
    Chen A, Blount A, Vaughan J, Brar B, Vale W.
    Endocrinology; 2004 May 20; 145(5):2445-57. PubMed ID: 14736736
    [Abstract] [Full Text] [Related]

  • 10. Urocortin in human placenta and maternal plasma.
    Watanabe F, Oki Y, Ozawa M, Masuzawa M, Iwabuchi M, Yoshimi T, Nishiguchi T, Iino K, Sasano H.
    Peptides; 1999 May 20; 20(2):205-9. PubMed ID: 10422876
    [Abstract] [Full Text] [Related]

  • 11. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM, Inoue K, Zhao Y, Rivier JE, Vale WW, Szücs A, Koob GF, Zorrilla EP.
    Neuropsychopharmacology; 2007 May 20; 32(5):1052-68. PubMed ID: 17019404
    [Abstract] [Full Text] [Related]

  • 12. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K, Nishiyama M, Tanaka Y, Noguchi T, Asaba K, Hossein PN, Nishioka T, Makino S.
    Peptides; 2004 Oct 20; 25(10):1711-21. PubMed ID: 15476938
    [Abstract] [Full Text] [Related]

  • 13. Effect of stress and adrenalectomy on urocortin II mRNA expression in the hypothalamic paraventricular nucleus of the rat.
    Tanaka Y, Makino S, Noguchi T, Tamura K, Kaneda T, Hashimoto K.
    Neuroendocrinology; 2003 Jul 20; 78(1):1-11. PubMed ID: 12869794
    [Abstract] [Full Text] [Related]

  • 14. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z, Csabafi K, Palotai M, Jászberényi M, Földesi I, Gardi J, Szabó G, Telegdy G.
    Neuropeptides; 2014 Feb 20; 48(1):15-20. PubMed ID: 24331779
    [Abstract] [Full Text] [Related]

  • 15. Colocalization of urocortin and neuronal nitric oxide synthase in the hypothalamus and Edinger-Westphal nucleus of the rat.
    Spina MG, Langnaese K, Orlando GF, Horn TF, Rivier J, Vale WW, Wolf G, Engelmann M.
    J Comp Neurol; 2004 Nov 15; 479(3):271-86. PubMed ID: 15457505
    [Abstract] [Full Text] [Related]

  • 16. Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.
    Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H.
    J Clin Endocrinol Metab; 2002 Jan 15; 87(1):340-6. PubMed ID: 11788672
    [Abstract] [Full Text] [Related]

  • 17. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
    Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE.
    Proc Natl Acad Sci U S A; 2001 Feb 27; 98(5):2843-8. PubMed ID: 11226328
    [Abstract] [Full Text] [Related]

  • 18. Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids.
    Chen A, Perrin M, Brar B, Li C, Jamieson P, Digruccio M, Lewis K, Vale W.
    Mol Endocrinol; 2005 Feb 27; 19(2):441-58. PubMed ID: 15514029
    [Abstract] [Full Text] [Related]

  • 19. Changes in adrenal status affect hypothalamic thyrotropin-releasing hormone gene expression in parallel with corticotropin-releasing hormone.
    Kakucska I, Qi Y, Lechan RM.
    Endocrinology; 1995 Jul 27; 136(7):2795-802. PubMed ID: 7789304
    [Abstract] [Full Text] [Related]

  • 20. Urocortin is not a significant regulator of intermittent electrofootshock-induced adrenocorticotropin secretion in the intact male rat.
    Turnbull AV, Vaughan J, Rivier JE, Vale WW, Rivier C.
    Endocrinology; 1999 Jan 27; 140(1):71-8. PubMed ID: 9886809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.